Willow Biosciences Plans $30 Million Recapitalization, Rebrands as Atlas Energy Corp

Willow Biosciences Inc. is undergoing a major transformation, including a $30 million recapitalization financing and a strategic reorganization that will see the company rebranded as Atlas Energy Corp. This transition involves a new executive team and board of directors led by key investors such as Mark Hodgson, with the company shifting its focus from its prior operations to become an international upstream oil and gas royalty and streaming company. The recapitalization includes a private placement and a share consolidation on a 1-for-5 basis to meet TSX Venture Exchange (TSXV) listing requirements, with completion expected around mid-June 2025. Upon closing, the company will delist from the Toronto Stock Exchange and begin trading on the TSXV under the ticker symbol ATLE. The reorganization represents a fundamental shift in the company’s market operations and strategy, aiming to build a diversified portfolio of royalty and streaming assets primarily in international markets, while selectively pursuing North American opportunities. Despite these strategic moves, financial challenges remain, as noted by analysts who cite ongoing losses and negative equity as risks to the company’s outlook.